American Heart Journal
Volume 149, Issue 5 , Pages 776-784 , May 2005

Evaluation and management of patients with uncontrolled systolic hypertension: Is another new paradigm really needed?

  • Gary F. Mitchell, MD

      Affiliations

    • Cardiovascular Engineering, Inc, Holliston, Mass
    • Corresponding Author InformationReprints not available from authors.
    • ,
  • Marc A. Pfeffer, MD, PhD

      Affiliations

    • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Mass

Received 25 January 2005 ,Accepted 25 January 2005.

References 

  1. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26:60–69
  2. Lloyd-Jones DM, Evans JC, Larson MG, et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594–599
  3. Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001;37:869–874
  4. Domanski M, Norman J, Wolz M, et al. Cardiovascular risk assessment using pulse pressure in the first National Health and Nutrition Examination Survey (NHANES I). Hypertension. 2001;38:793–797
  5. Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA. 1999;281:634–639
  6. Domanski MJ, Davis BR, Pfeffer MA, et al. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension. 1999;34:375–380
  7. Mitchell GF, Moyé LA, Braunwald E, et al. Sphygmomanometrically-determined pulse pressure is a powerful independent predictor of recurrent events following myocardial infarction in patients with impaired left ventricular function. Circulation. 1997;96:4254–4260
  8. Domanski MJ, Mitchell GF, Norman J, et al. Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol. 1999;33:951–958
  9. Domanski M, Mitchell G, Pfeffer M, et al. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 2002;287:2677–2683
  10. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957–1963
  11. Izzo JL, Levy D, Black HR. Clinical advisory statement. Importance of systolic blood pressure in older Americans. Hypertension. 2000;35:1021–1024
  12. Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation. 1999;100:354–360
  13. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older patients with isolated systolic hypertension. JAMA. 1991;265:3255–3264
  14. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308–315
  15. Galarza CR, Alfie J, Waisman GD, et al. Diastolic pressure underestimates age-related hemodynamic impairment. Hypertension. 1997;30:809–816
  16. Avolio AP, Deng FQ, Li WQ, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation. 1985;71:202–210
  17. Heijden-Spek JJ, Staessen JA, Fagard RH, et al. Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension. 2000;35:637–642
  18. Mitchell GF, Tardif JC, Arnold JM, et al. Pulsatile hemodynamics in congestive heart failure. Hypertension. 2001;38:1433–1439
  19. Buckberg GD, Fixler DE, Archie JP, et al. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res. 1972;30:67–81
  20. Watanabe H, Ohtsuka S, Kakihana M, et al. Coronary circulation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol. 1993;21:1497–1506
  21. Kelly R, Fitchett D. Noninvasive determination of aortic input impedance and external left ventricular power output: a validation and repeatability study of a new technique. J Am Coll Cardiol. 1992;20:952–963
  22. Mitchell GF, Izzo JL, Lacourcière Y, et al. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the Conduit Hemodynamics of Omapatrilat International Research Study. Circulation. 2002;105:2955–2961
  23. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241
  24. Mitchell GF, Pfeffer MA, Finn PV, et al. Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. Circulation. 1996;94:2923–2929
  25. Cholley BP, Shroff SG, Sandelski J, et al. Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients. Circulation. 1995;91:1052–1062
  26. Marcus RH, Korcarz C, McCray G, et al. Noninvasive method for determination of arterial compliance using Doppler echocardiography and subclavian pulse tracings: validation and clinical application of a physiologic model of the circulation. Circulation. 1994;89:2688–2699
  27. Avolio AP, Clyde KM, Beard TC, et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis. 1986;6:166–169
  28. Moore TJ, Conlin PR, Ard J, et al. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension. 2001;38:155–158
  29. Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 1993;88:1456–1462
  30. Cameron JD, Dart AM. Exercise training increases total systemic arterial compliance in humans. Am J Physiol. 1994;266:H693–H701
  31. Tanaka H, Dinenno FA, Monahan KD, et al. Aging, habitual exercise, and dynamic arterial compliance. Circulation. 2000;102:1270–1275
  32. Glorioso N, Troffa C, Filigheddu F, et al. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension. 1999;34:1281–1286
  33. Ferrier KE, Muhlmann MH, Baguet JP, et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol. 2002;39:1020–1025
  34. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;65:3255–3264
  35. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757–764
  36. Ekbom T, Dahlof B, Hansson L, et al. Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study. J Hypertens. 1992;10:1525–1530
  37. Girerd X, Giannattasio C, Moulin C, et al. Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. J Am Coll Cardiol. 1998;31:1064–1073
  38. Heesen WF, Beltman FW, Smit AJ, et al. Effect of quinapril and triamterene̸hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension. J Cardiovasc Pharmacol. 1998;31:187–194
  39. The ALLHAT officers and coordinators for the ALLHAT collaborative research group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–2997
  40. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2000;283:1967–1975
  41. Safar ME, van Bortel LM, Struijker-Boudier HA. Resistance and conduit arteries following converting enzyme inhibition in hypertension. J Vasc Res. 1997;34:67–81
  42. Ting CT, Chen CH, Chang MS, et al. Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance, and impedance. Hypertension. 1995;26:524–530
  43. De Cesaris R, Ranieri G, Filitti V, et al. Large artery compliance in essential hypertension: effects of calcium antagonism and beta-blocking. Am J Hypertens. 1992;5:624–628
  44. Pannier BM, Lafleche AB, Girerd XJ, et al. Arterial stiffness and wave reflections following acute calcium blockade in essential hypertension. Am J Hypertens. 1994;7:168–176
  45. Shimamoto H, Shimamoto Y. Lisinopril reverses left ventricular hypertrophy through improved aortic compliance. Hypertension. 1996;28:457–463
  46. Quaschning T, d'Uscio LV, Shaw S, et al. Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension. Hypertension. 2001;37:1108–1113

PII: S0002-8703(05)00109-2

doi: 10.1016/j.ahj.2005.01.038

American Heart Journal
Volume 149, Issue 5 , Pages 776-784 , May 2005

Article Tools

* Image Usage & Resolution